JPH0354466A - Immunoassay reagent and immunoassay - Google Patents

Immunoassay reagent and immunoassay

Info

Publication number
JPH0354466A
JPH0354466A JP19026189A JP19026189A JPH0354466A JP H0354466 A JPH0354466 A JP H0354466A JP 19026189 A JP19026189 A JP 19026189A JP 19026189 A JP19026189 A JP 19026189A JP H0354466 A JPH0354466 A JP H0354466A
Authority
JP
Japan
Prior art keywords
serum albumin
antibody
reagent
antigen
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19026189A
Other languages
Japanese (ja)
Inventor
Junichiro Shinoda
篠田 潤一郎
Michiya Nakagawa
道也 中川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP19026189A priority Critical patent/JPH0354466A/en
Publication of JPH0354466A publication Critical patent/JPH0354466A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To enhance storage stability and to avoid cross reaction by containing an insoluble carrier having an antibody supported thereon and the scrum albumin of the animal to be immunized used in the preparation of said antibody in a measuring reagent. CONSTITUTION:An insoluble carrier on which the antibody corresponding to the antigen (e.g., human albumin) in a specimen to be measured is supported and the serum albumin originating from the animal used in the preparation of the antibody are contained in a measuring reagent. The content of this serum albumin is determined according to the use mode of this reagent but about 0,01-8 wt.% in general, pref., about 1-2 wt.%. By this method, the storage stability of the reagent is effectively enhanced as compared with a case using serum albumin of a different kind of an animal. The cross reaction generated between serum albumin to be used and the antigen according to circumstances can be avoided.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、抗体が担持された不溶性担体の免疫学的特異
反応による凝集の程度を検出することにより試料中の抗
原を測定するための試薬及び測定方法に関し、特に、保
存安定性が良くかつ交差反応の影響を回避し得る試薬及
び測定方法に関する。
Detailed Description of the Invention [Field of Industrial Application] The present invention provides a reagent for measuring an antigen in a sample by detecting the degree of agglutination caused by an immunological specific reaction of an insoluble carrier carrying an antibody. The present invention relates to a reagent and a measurement method, and particularly to a reagent and a measurement method that have good storage stability and can avoid the effects of cross-reactivity.

〔従来の技術〕[Conventional technology]

従来より、被測定試料中の抗原に対応する抗体を不溶性
担体に担持させ、免疫反応により生じた不溶性担体の凝
集の程度を検出する免疫学的測定方法が広く用いられて
いる。この種の免疫学的測定方法において測定精度を高
めるには、免疫反応の特異性を高めることが必要であり
、種々の方法が提案されている. 特開昭57−9723号に開示されている方法では、特
異性を高めるために、免疫グロプリンの構或威分が安定
化剤として用いられており、また免疫グロブリンの構或
戒分に加えて牛血清アルフミンも共存させた例が開示さ
れている。
Conventionally, immunoassay methods have been widely used in which an insoluble carrier supports an antibody corresponding to an antigen in a sample to be measured, and the degree of aggregation of the insoluble carrier caused by an immune reaction is detected. In order to increase the measurement accuracy in this type of immunological measurement method, it is necessary to increase the specificity of the immune reaction, and various methods have been proposed. In the method disclosed in JP-A No. 57-9723, a component of immunoglobulin is used as a stabilizing agent in order to increase specificity, and in addition to the component of immunoglobulin, An example has been disclosed in which bovine serum albumin was also present.

他方、特開昭60−256057号には、免疫学的測定
法において、非特異反応を抑制するために、保護コロイ
ドとしての安定化作用を有する物質として血清アルブミ
ンが開示されている。ここでも、血清アルブミンとして
は、牛血清アルブミンを用いることが開示されている。
On the other hand, JP-A-60-256057 discloses serum albumin as a substance having a stabilizing effect as a protective colloid in order to suppress non-specific reactions in immunoassays. Here, too, it is disclosed that bovine serum albumin is used as the serum albumin.

〔発明が解決しようとする課題) 上述した特開昭57−9723号及び特開昭60−25
6057号に記載の方法では、何れにおいても非特異反
応を抑制する安定化剤として牛血清アルブミンを使用し
得る旨が示されている.しかしながら、使用する抗体の
産生勅物種に関わらず、牛血清アルプミンを用いた場合
には、試薬の保存安定性が充分なものではなかった.さ
らにまた、使用する抗体に対して対応する抗原ばかりで
なく牛血清アルブミンも反応する、いわゆる交差反応の
可能性も常に存在していた。特に、抗原がヒトアルブミ
ンである場合には、この交差反応を回避することができ
なかった, 本発明の目的は、免疫反応により生じた不溶性担体の凝
集の程度を検出することにより被測定試料中の抗原を測
定するための試薬及び測定方法であって、試薬の保存安
定性において優れ、かつ交差反応の影響を回避すること
ができるものを提供することにある. 〔課題を解決するための手段] 本願発明者らは、試料中の抗原に対応する抗体を不溶性
担体に担持させ、免疫反応により生じた不溶性担体の凝
集程度を検出する試薬及び方法において、抗体作戒時に
用いた被免疫動物種の血清アルブミンを反応系に含有さ
せれば、保存安定性が良く、かつ交差反応を回避し得る
ことを見出し、本発明を威すに至った. すなわち、本発明は、被測定試料中の抗原に対応する抗
体が担持された不溶性担体と、この抗体作成に用いた被
免疫動物種の血清アルブ旦ンとを含有することを特徴と
する免疫学的測定試薬、並びに被測定試料中の抗原に対
応する抗体を不溶性担体に担持させ、免疫反応により生
じた不溶性担体の凝集の程度を検出することにより被測
定試料中に含有された抗原を検出する方法において、反
応系中に抗体作成時に用いた被免疫動物種の血清アルブ
ミンを含有させることを特徴とする免疫学的♂り定方法
である. 本発明の試薬及び測定方法における測定対象物としては
、ハプテン、ポリベブチド、ステロイド及び多糖類等の
他、ヒトアルブミンやCRPのような種々の抗原となる
蛋白質が挙げられる。そして、本発明はヒトアルブミン
の測定において特に好適に使用される。
[Problem to be solved by the invention] The above-mentioned JP-A-57-9723 and JP-A-60-25
In all of the methods described in No. 6057, it has been shown that bovine serum albumin can be used as a stabilizer to suppress non-specific reactions. However, regardless of the certified species of antibody used, when bovine serum albumin is used, the storage stability of the reagent is not sufficient. Furthermore, there was always the possibility that the antibody used would react not only with the corresponding antigen but also with bovine serum albumin, a so-called cross-reactivity. In particular, when the antigen is human albumin, this cross-reactivity cannot be avoided. The object of the present invention is to provide a reagent and a measuring method for measuring antigens, which have excellent storage stability and can avoid the effects of cross-reactivity. [Means for Solving the Problems] The present inventors have developed a reagent and method for supporting an antibody corresponding to an antigen in a sample on an insoluble carrier and detecting the degree of agglutination of the insoluble carrier caused by an immune reaction. The present inventors have discovered that if the reaction system contains serum albumin from the immunized animal species used during the vaccination, storage stability is good and cross-reactivity can be avoided, and the present invention has been achieved. That is, the present invention provides an immunology method comprising an insoluble carrier carrying an antibody corresponding to an antigen in a sample to be measured, and serum albumin of the immunized animal species used to prepare the antibody. The antigen contained in the sample to be measured is detected by supporting a specific measurement reagent and an antibody corresponding to the antigen in the sample to be measured on an insoluble carrier, and detecting the degree of aggregation of the insoluble carrier caused by an immune reaction. This is an immunological determination method characterized by containing serum albumin of the immunized animal species used during antibody production in the reaction system. Objects to be measured in the reagent and measurement method of the present invention include haptens, polypeptides, steroids, polysaccharides, and various antigenic proteins such as human albumin and CRP. The present invention is particularly suitable for use in measuring human albumin.

また、本発明において用い得る抗体としては、上記各種
の抗原に対して特異的な抗体蛋白質であり、.免疫グロ
プリンやその断片、例えばF(ab′)2を例示するこ
とができる. 不溶性担体としては、無機物質粉末、有機高分子粉末、
微生物、血球または細胞膜片等が考えられる。より具体
的には、無機物質粉末としては、シリカ、アルミナまた
は金、チタン、鉄もしくはニソケル等の金属片を例示す
ることができる.有機高分子粉末としては、ラテックス
、不溶性アガロース、セルロースまたは不溶性デキスト
ラン等が例示され、好ましくは、ラテンクスが用いられ
る。ラテックスとしては、ボリスチレン、スチレンース
チレンスルホン酸塩共重合体、メタクリル酸重合体、ア
クリル酸重合体、アクリロニトリルブタジエン共重合体
または塩化ビニルーアクリル酸エステル共重合体等を例
示することができる。
In addition, the antibodies that can be used in the present invention include antibody proteins specific to the various antigens mentioned above. Examples include immunoglobulins and fragments thereof, such as F(ab')2. Insoluble carriers include inorganic powder, organic polymer powder,
Possible sources include microorganisms, blood cells, and cell membrane fragments. More specifically, examples of the inorganic substance powder include silica, alumina, and metal pieces such as gold, titanium, iron, and Nisokel. Examples of the organic polymer powder include latex, insoluble agarose, cellulose, and insoluble dextran, and preferably latex is used. Examples of the latex include polystyrene, styrene-styrene sulfonate copolymer, methacrylic acid polymer, acrylic acid polymer, acrylonitrile butadiene copolymer, and vinyl chloride-acrylic acid ester copolymer.

ラテックスは、通常、反応媒体に悲濁されたラテックス
懸濁液の状態で用いられる. 上記不溶性担体の平均粒径は、測定対象物質の検出濃度
あるいは使用する測定機器により適宜選択されるもので
あるが、0.05〜1.0μm程度のものが好適に用い
られる. 不溶性担体を分散あるいは懸濁させる反応媒体としては
、水や緩衝液のような水性媒体を例示することができる
.また、場合によっては、尿等の検体をそのまま反応媒
体とすることもできる。
Latex is usually used in the form of a latex suspension in a reaction medium. The average particle size of the above-mentioned insoluble carrier is appropriately selected depending on the detected concentration of the substance to be measured or the measuring instrument used, but a particle size of about 0.05 to 1.0 μm is preferably used. Examples of reaction media for dispersing or suspending insoluble carriers include aqueous media such as water and buffer solutions. Further, in some cases, a specimen such as urine can be used as a reaction medium as it is.

本発明において抗体を上記不溶性担体に担持(感作)さ
せるには、物理的あるいは化学的結合を利用した公知の
方法を用いることができる。
In the present invention, to support (sensitize) the antibody on the above-mentioned insoluble carrier, a known method using physical or chemical bonding can be used.

本発明の測定試薬では、上記の抗体が感作された不溶性
担体と、上記抗体を作戒するのに用いた勅物種由来の血
清アルブミンとが含有されている.試薬中の該血清アル
ブミンの含有量は、この試薬の使用される態様によって
決められるので、一律には決められないが、通常0.O
l〜8重景%、好ましくは0.1〜2重量%程度である
The measurement reagent of the present invention contains an insoluble carrier sensitized with the above antibody and serum albumin derived from a reptile species used to sensitize the above antibody. The content of serum albumin in the reagent is determined depending on the manner in which the reagent is used, so it cannot be determined uniformly, but it is usually 0. O
The amount is about 1 to 8% by weight, preferably about 0.1 to 2% by weight.

また、本発明の測定方法では、反応系中に抗体の作戊時
に用いた被免疫動物種の血清アルブミンを含有させる.
該血清アルブミンを反応系中に含有させる方法は、上記
感作を行った後に、該血清アルブミンを、不溶性担体の
分散または懸濁された反応媒体中に添加する方法、被測
定試料の希釈液中に該血清アルブミンを添加する方法な
ど種々の態様が考えられるが、何れでもよい。。血清ア
ルブミンの添加は、血清アルプミンを含有する溶液を加
えることにより、あるいは粉末状の血清アルプ兆ンを添
加することによってもよい.なお、反応系中の血清アル
ブミンの含有量は、測定対象物質の検出濃度等により適
宜選ばれるものであるが、通常0.01〜8重量%、好
ましくは0.1〜5.0垂景%程度の濃度とされる。
In addition, in the measurement method of the present invention, serum albumin of the immunized animal species used during antibody production is contained in the reaction system.
The method of incorporating the serum albumin into the reaction system includes adding the serum albumin into a reaction medium in which an insoluble carrier is dispersed or suspended after the above-mentioned sensitization, and adding the serum albumin into a diluted solution of the sample to be measured. Various methods can be considered, such as a method of adding the serum albumin to the sample, and any method may be used. . Serum albumin may be added by adding a solution containing serum albumin or by adding powdered serum albumin. The content of serum albumin in the reaction system is appropriately selected depending on the detected concentration of the substance to be measured, etc., but is usually 0.01 to 8% by weight, preferably 0.1 to 5.0% by weight. It is said that the concentration is about 100%.

なお、本発明の免疫学的測定方法において、凝集の程度
を検出する具体的な方法としては、凝集の有無を肉眼で
判定する方法、並びに反応液に光を照射し、散乱光ある
いは透過光を測定する光学的方法の何れをも用い得る。
In the immunoassay method of the present invention, specific methods for detecting the degree of agglutination include a method of visually determining the presence or absence of agglutination, and a method of irradiating the reaction solution with light and detecting scattered or transmitted light. Any optical method of measuring can be used.

すなわち、肉眼判定方法により、被測定試料中における
抗原の有無を判定したり、あるいは抗原を半定量的に検
出してもよく、また光学的測定方法により抗原を定量し
てもよい, また、本発明をヒトアルブミンを測定する場合に通用す
ると、保存安定性が良いばかりでな《、被免疫動物種と
異なる動物種の血清アルブミンを使用したときに見られ
る、ヒトアルブミンと該血清アルブミンとの交差が回避
される試薬及び測定方法が得られるので、本発明の効果
が特に発揮される.ヒトアルブミンを含有する被検検体
としては、何れも適用可能であるが、例えば尿及び血清
検体等が例示される. 〔作用及び発明の効果〕 本発明の免疫学的測定試薬には、不溶性担体に担持され
る抗体の作戒時に用いたのと同し動物種の血清アルブミ
ンが含有されているので、異種の勅物種の血清アルプミ
ンを用いた場合に比較し、試薬の保存安定性が効果的に
高められる.この理由は、抗体と血清アルブミンとの非
特異的相互作用が、抗体の作戒時に用いたのと同じ勅物
種の血清アルプミンを使用した場合には、生じ難いため
と准定される。さらに、本発明の免疫学的測定試薬にお
いては、使用する血清アルブミンと抗原との間に起こり
得る交差が、抗体作成時に用いたのと同し動物種の血清
アルブミンを使用するので回避される。同様に、本発明
の免疫学的測定方法においても、反応系中に被免疫動物
種の血清アルブミンが含有されるので、抗体と血清アル
ブミンとの非特異的相互作用及び交差反応を回避するこ
とができる.従って、本発明の試薬及び測定方法によれ
ば、免疫学的特異性を効果的に高め得るため、被測定試
料中の抗原を正確に測定することが可能となる. また、本発明の免疫学的測定試薬及び測定方法をヒトア
ルプミンの測定に適用する場合には、保存安定性が良い
だけでなく、被免疫動物種と異なる動物種の血清アルブ
ミンを使用した時に見られる、ヒトアルブミンと該血清
アルブミンとの交差が回避された試薬及び測定方法が得
られるので、ヒトアルブ1ンを常に正確に測定すること
が可能となる. 〔実施例の説明〕 尖脂班上 抗ヒトアルブミン抗体(ウサギ由来)をlmg/ m 
12のIgcl度で含有する0.1Mグリシン緩衝液(
pH=9.0)を調製する。この抗ヒトアルブミン抗体
含有グリシン緩衝液1 0mfに千均粒径が0.13μ
mのポリスチレンラテックス(積水化学工業株式会社製
、固形分10%)lm2を加え、37゜Cで60分間撹
拌し、しかる後、4゜Cの温度で60分間遠心分Xff
l(1800Orpm)を行う。
That is, the presence or absence of an antigen in a sample to be measured may be determined by a visual determination method, or the antigen may be detected semi-quantitatively, or the antigen may be quantified by an optical measurement method. If the invention is applied to the measurement of human albumin, it will not only have good storage stability, but also reduce the cross-reactivity between human albumin and serum albumin that occurs when serum albumin from an animal species different from the immunized animal species is used. Since a reagent and a measuring method can be obtained that avoid this, the effects of the present invention are particularly exhibited. Any specimen containing human albumin can be used, and examples thereof include urine and serum specimens. [Action and Effects of the Invention] The immunoassay reagent of the present invention contains serum albumin of the same animal species as that used in preparing the antibody supported on the insoluble carrier. The storage stability of the reagent is effectively increased compared to when serum albumin of different species is used. The reason for this is assumed to be that non-specific interaction between the antibody and serum albumin is unlikely to occur when serum albumin of the same species as that used in preparing the antibody is used. Furthermore, in the immunoassay reagent of the present invention, possible cross-over between the serum albumin used and the antigen is avoided because serum albumin of the same animal species as used for producing the antibody is used. Similarly, in the immunoassay method of the present invention, since the reaction system contains serum albumin of the immunized animal species, nonspecific interactions and cross-reactions between antibodies and serum albumin can be avoided. can. Therefore, according to the reagent and measurement method of the present invention, immunological specificity can be effectively increased, making it possible to accurately measure antigens in a sample to be measured. In addition, when applying the immunological measurement reagent and measurement method of the present invention to the measurement of human albumin, it is important to not only have good storage stability, but also to improve the results when using serum albumin of an animal species different from the immunized animal species. Since the present invention provides a reagent and a measurement method that avoids the interaction between human albumin and serum albumin, human albumin can be measured accurately at all times. [Explanation of Examples] Anti-human albumin antibody (derived from rabbit) was added to lmg/m
0.1 M glycine buffer containing at an Igcl degree of 12 (
pH=9.0). In 10mf of this anti-human albumin antibody-containing glycine buffer, the average particle size was 0.13μ.
Add 1m2 of polystyrene latex (manufactured by Sekisui Chemical Co., Ltd., solid content 10%), stir at 37°C for 60 minutes, and then centrifuge at 4°C for 60 minutes.
1 (1800 rpm).

遠心後、上清を捨て去った沈澱物に、濃度l.2重量%
のウサギ血清アルブミン含有0.1Mグリノン緩衝液(
pH=9.0)lomfを加え、ラテノクスを悲濁させ
て、測定試薬を得る.上記測定試薬を4”Cの温度で保
存し、試薬100μ乏に、希釈液として上記ウサギ血清
アルブビン含有グリシンl1衝液900μlを混合し、
セル長5mmのガラスセルにより700nmの吸光度を
測定した。
After centrifugation, the supernatant was discarded and the precipitate was added to a concentration of l. 2% by weight
of rabbit serum albumin in 0.1M glinone buffer (
Add LOMF (pH = 9.0) to make the latex cloudy and obtain a measurement reagent. Store the above measurement reagent at a temperature of 4''C, mix 900 μl of the above rabbit serum albumin-containing glycine 11 buffer solution as a diluent with 100 μl of the reagent,
Absorbance at 700 nm was measured using a glass cell with a cell length of 5 mm.

止鮫史上 抗ヒトアルブミン抗体(ウサギ由来)をlmg/ m 
lのIg(4度となるように0.1Mグリシン緩衝fi
(pH=9.0)に含有させた抗ヒトアルブミン抗体含
有グリシン緩衝液10mlに、平均粒径が0.13μm
のポリスチレンラテックス(積水化学工業株式会社製、
固形分10%)lmlを加え、37゜Cで60分撹拌し
、次に4 ’Cの温度で60分間遠心分離(18000
rpm)する.遠心後、上清を捨て去った沈澱物に、1
.2重量%の牛血清アルプミン含有0.1Mグリシン緩
衝液(pH=9.0)lor+/!を加え、ラテックス
をg濁させて試薬を得る。この測定試薬を4゜Cの温度
で保存し、試薬100μeに、希釈液として上記生血清
アルブミン含有グリシン緩衝液900μlを混合し、セ
ル長5圓のガラスセルにより700nmの吸光度を測定
した. 上記実施例l及び比較例lにおける試薬保存期間と70
0nmにおける濁度の変化の関係を下記の第1表に示す
Anti-human albumin antibody (derived from rabbit) in the history of sharks at lmg/m
l of Ig (0.1M glycine buffered fi to 4 degrees
In 10 ml of glycine buffer containing anti-human albumin antibody (pH = 9.0), the average particle size was 0.13 μm.
polystyrene latex (manufactured by Sekisui Chemical Co., Ltd.,
10% solids) was added, stirred at 37 °C for 60 min, and then centrifuged at 4'C for 60 min (18000 °C).
rpm). After centrifugation, add 1 to the precipitate after discarding the supernatant.
.. 0.1M glycine buffer containing 2% by weight bovine serum albumin (pH=9.0)lor+/! is added to make the latex cloudy to obtain a reagent. This measurement reagent was stored at a temperature of 4°C, and 100 μe of the reagent was mixed with 900 μl of the above glycine buffer containing live serum albumin as a diluent, and the absorbance at 700 nm was measured using a glass cell with a cell length of 5 μm. Reagent storage period and 70 days in Example 1 and Comparative Example 1 above
The relationship between changes in turbidity at 0 nm is shown in Table 1 below.

第  I  表 第1表より、従来法すなわち比較例1では、測定試薬自
身の自己凝集が生し、保存期間の長期化に連れて濁度が
急速に上昇していくことがわかる.これに対して、実施
例1の測定拭薬では、自己凝集を起こさないため、濁度
の上界がほとんどなく、保存安定性に優れていることが
わかる。
Table I From Table 1, it can be seen that in the conventional method, that is, Comparative Example 1, self-aggregation of the measurement reagent itself occurs, and the turbidity increases rapidly as the storage period becomes longer. On the other hand, it can be seen that the measurement wipe of Example 1 does not cause self-aggregation, has almost no upper limit of turbidity, and has excellent storage stability.

犬友池1 抗ヒトCRP抗体(ヤギ由来)のIgGifi度が1 
m g / m Eとなるように0.1Mグリシン1M
 fIi1 (p H=9.0) に含有させ7或る抗
!=}CRP抗体含有グリシン緩衝液10m乏に、平均
粒径が0.24μmのラテックス(積水化学工業株式会
社製、固形分10%)lmffiを加え、37゛Cの温
度で60分間撹拌し、次に、4゜Cの温度で60分間遠
心分M(18000rpm)する。遠心後、上清を捨て
去った沈澱物に、0.7重量%の濃度でヤギ血清アルブ
ミンを含有する0.1Mグリシ7M街液(pH=9.0
)10mfを加え、ラテックスを懸濁させて測定試薬を
得る。この測定試薬を4 ’Cの塩度で保存し、該測定
試薬100μlに、希釈液として上記ヤギ血清アルブミ
ン含有グリシン緩衝液900μlを混合し、セル長5鄭
のガラスセルにより7 0 0 nmの吸光度を測定し
た.比較例2 抗ヒトCRP抗体(ヤギ由来)のIgG4度が1 m 
B / 1 m lとなるように、該抗ヒトCRP抗体
をO.IMグリシン緩衝液(pH9.0)に混合し、こ
の抗ヒ}CRP抗体含有グリシン媛衝液10rr+j!
に、平均粒径が0.24μmのラテノクス(積水化学工
業株式会社製、固形分10%)1mlを加え、37゜C
で60分間撹拌し、次に4℃の温度で60分間遠心分離
(18000rpm)する.遠心後、上・清を捨て去っ
た沈澱物に、0.7重量%の牛血清アルブミンを含有す
るO.tMグリシン緩衝液(pH=9.0)10rr+
j!を加え、ラテックスを懸濁させて測定試薬を得る。
Inutoike 1 Anti-human CRP antibody (goat-derived) IgGi degree is 1
0.1M glycine 1M so that mg/mE
fIi1 (pH=9.0) contains 7 certain anti-! =}Lmffi latex (manufactured by Sekisui Chemical Co., Ltd., solid content 10%) with an average particle size of 0.24 μm was added to 10 m of glycine buffer containing CRP antibody, stirred for 60 minutes at a temperature of 37°C, and then Then, centrifuge M (18,000 rpm) for 60 minutes at a temperature of 4°C. After centrifugation, the supernatant was discarded and the precipitate was mixed with 0.1M glycine 7M street solution (pH = 9.0) containing goat serum albumin at a concentration of 0.7% by weight.
) Add 10 mf and suspend the latex to obtain a measurement reagent. This measurement reagent was stored at a salinity of 4'C, and 100 μl of the measurement reagent was mixed with 900 μl of the above glycine buffer containing goat serum albumin as a diluent, and the absorbance at 700 nm was measured using a glass cell with a cell length of 5. was measured. Comparative Example 2 IgG4 degree of anti-human CRP antibody (goat origin) is 1 m
The anti-human CRP antibody was added to O.B/1 ml. Mix with IM glycine buffer (pH 9.0) and add 10rr+j of this glycine buffer solution containing anti-human CRP antibody!
1 ml of latenox (manufactured by Sekisui Chemical Co., Ltd., solid content 10%) with an average particle size of 0.24 μm was added to the mixture, and heated at 37°C.
Stir for 60 minutes and then centrifuge (18,000 rpm) for 60 minutes at a temperature of 4°C. After centrifugation, the supernatant was discarded and the precipitate was added to the precipitate containing 0.7% by weight of bovine serum albumin. tM glycine buffer (pH=9.0) 10rr+
j! is added to suspend the latex to obtain a measurement reagent.

この測定試薬を4゜Cで保存し、該測定試薬l00μi
に、希釈液として上記生血清アルブミン含有グリシン緩
衝液900μlを混合し、セル長5IIIImのガラス
セルを用いて、700nmの吸光度を測定した。
Store this measurement reagent at 4°C, and store 100 μi of this measurement reagent.
900 μl of the above-mentioned glycine buffer containing live serum albumin was mixed as a diluent, and the absorbance at 700 nm was measured using a glass cell with a cell length of 5IIIm.

上記実施例2及び比較例2における試薬の保存期間と7
00nmにおける渇度の変化を下記の第2表に示す。
Reagent storage period and 7 in Example 2 and Comparative Example 2 above
The changes in thirst at 00 nm are shown in Table 2 below.

第 2 表 第2表から、従来法(比較例2)の測定試薬では、測定
試薬自身において自己凝集が起こっており、それによっ
て保存期間の長期化に伴って濁度が急激に上昇すること
がわかる。これに対して、本発明(実施例2)の測定試
薬では、自己凝集が生しないため、濁度の上昇がほとん
どなく、保存安定性に優れていることがわかる。
Table 2 From Table 2, it can be seen that in the measurement reagent of the conventional method (Comparative Example 2), self-aggregation occurs in the measurement reagent itself, which causes a rapid increase in turbidity as the storage period becomes longer. Recognize. On the other hand, in the measurement reagent of the present invention (Example 2), since self-aggregation does not occur, there is almost no increase in turbidity, and it can be seen that it has excellent storage stability.

Claims (4)

【特許請求の範囲】[Claims] (1)被測定試料中の抗原に対応する抗体が担持された
不溶性担体と、前記抗体の作成に用いた被免疫動物種の
血清アルブミンとを含有することを特徴とする免疫学的
測定試薬。
(1) An immunological assay reagent comprising an insoluble carrier carrying an antibody corresponding to an antigen in a sample to be measured, and serum albumin of the immunized animal species used to prepare the antibody.
(2)前記被測定試料中の抗原がヒトアルブミンである
請求項1に記載の免疫学的測定試薬。
(2) The immunoassay reagent according to claim 1, wherein the antigen in the sample to be measured is human albumin.
(3)被測定試料中の抗原に対応する抗体を不溶性担体
に担持させ、免疫反応により生じた不溶性担体の凝集の
程度を検出することにより、被測定試料中に含有された
抗原を検出する方法において、反応系中に抗体の作成時
に用いた被免疫動物種の血清アルブミンを含有させるこ
とを特徴とする免疫学的測定方法。
(3) A method of detecting an antigen contained in a sample to be measured by supporting an antibody corresponding to the antigen in the sample to be measured on an insoluble carrier and detecting the degree of aggregation of the insoluble carrier caused by an immune reaction. An immunoassay method characterized in that the reaction system contains serum albumin of the immunized animal species used in producing the antibody.
(4)前記被測定試料中の抗原がヒトアルブミンである
請求項3に記載の免疫学的測定方法。
(4) The immunoassay method according to claim 3, wherein the antigen in the sample to be measured is human albumin.
JP19026189A 1989-07-21 1989-07-21 Immunoassay reagent and immunoassay Pending JPH0354466A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19026189A JPH0354466A (en) 1989-07-21 1989-07-21 Immunoassay reagent and immunoassay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19026189A JPH0354466A (en) 1989-07-21 1989-07-21 Immunoassay reagent and immunoassay

Publications (1)

Publication Number Publication Date
JPH0354466A true JPH0354466A (en) 1991-03-08

Family

ID=16255203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19026189A Pending JPH0354466A (en) 1989-07-21 1989-07-21 Immunoassay reagent and immunoassay

Country Status (1)

Country Link
JP (1) JPH0354466A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5631648A (en) * 1979-06-19 1981-03-31 Siber George Test in which cohesion is caused by contact with body fluid containing antigen and method of preparing reagent for said test
JPS6165162A (en) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst Non-specific reactive absorvent in immunilogical measuring method using monoclonal antibody
JPS63145960A (en) * 1986-06-23 1988-06-18 Meidensha Electric Mfg Co Ltd Non-singular adsorption inhibitor for labeled antibody

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5631648A (en) * 1979-06-19 1981-03-31 Siber George Test in which cohesion is caused by contact with body fluid containing antigen and method of preparing reagent for said test
JPS6165162A (en) * 1984-09-05 1986-04-03 Chemo Sero Therapeut Res Inst Non-specific reactive absorvent in immunilogical measuring method using monoclonal antibody
JPS63145960A (en) * 1986-06-23 1988-06-18 Meidensha Electric Mfg Co Ltd Non-singular adsorption inhibitor for labeled antibody

Similar Documents

Publication Publication Date Title
JP2688402B2 (en) Reduction of hook effect in immunoassay with particulate carrier material
JP2009098138A (en) Method of high sensitive immunoassay
JP5362797B2 (en) Aggregation reaction stabilization method
US5043289A (en) Method and device for assaying immunologically reactive substances of clinical interest
JP3899029B2 (en) Immunological analysis method
JPH08211060A (en) Method for bonding antibody to new latex substrate and utilization of method in immunoassay
JP4086266B2 (en) Immunoassay method
JP2018173334A (en) Method for immunological measurement and reagent kit used for the same
JP2682697B2 (en) Immunoassay reagents and immunoassays
WO2010013525A1 (en) Method of assaying complex and kit to be used therefor
JPS6367865B2 (en)
JP2004325414A (en) Method and kit for measuring immunity
JPH0354466A (en) Immunoassay reagent and immunoassay
JP3220546B2 (en) Method for measuring antigen or antibody in the presence of immune complex
JPH1123573A (en) Immunological measuring method
JPH026023B2 (en)
JP5177677B2 (en) Method for measuring antigen and antibody against the antigen, and measuring reagent used therefor
JP3328053B2 (en) Determination of antibody or antigen concentration by immunoagglutination
JPH0712818A (en) Immunological detection
JP2003344410A (en) Immuno-measurement reagent and immuno-measurement method
JP2012078161A (en) Measuring method of measuring target substance in sample, measuring reagent and method for improving measurement value difference
JP3246978B2 (en) Method for producing reagent for measuring antigen or antibody
JP2009085703A (en) Method of high-sensitivity immunoassay
JP3715736B2 (en) Method for producing anti-treponema antibody measuring reagent and anti-treponema antibody measuring reagent
JPH0552846A (en) Immune measurement method